Evaluation of Rituximab Dosage for ABO-Incompatible Living-donor Kidney Transplantation
Author:
Publisher
Elsevier BV
Subject
Transplantation,Surgery
Reference9 articles.
1. Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis;Sawada;Transplantation,2002
2. Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem cell transplantation;Tsai;Bone Marrow Transplant,1999
3. Improved graft survival in ABO-incompatible living donor kidney transplantation;Kaihara;Transplant Proc,2005
4. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation;Ashimine;Kidney Int,2014
5. Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience;Hatakeyama;Transplant Proc,2014
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ABO-Incompatible Renal Transplant: A Single-Center Experience from India;Indian Journal of Nephrology;2023-06-05
2. Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach;BMC Nephrology;2023-05-26
3. Monthly Mini-Dose Rituximab for Primary Membranous Nephropathy: A Different Approach;2022-12-07
4. Liver Failure Has Higher IgG ABO Blood Group Isoagglutinin Titer than Kidney Failure;The Korean Journal of Blood Transfusion;2021-08-31
5. Comparison of Hamstrings and Quadriceps Femoris Muscle Thickness Increment between Agonist-Antagonist Paired Set and Traditional Set Resistance Training in Untrained Healthy Subjects;Surabaya Physical Medicine and Rehabilitation Journal;2021-08-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3